{"date":"2025-04-28T10:29","headerImageUrl":"https://structuredproducts-ch-pub-uat.leonteq.com/product-news/product-homepage-banner/rfb_earnings_action_leonteq_structured_products_product+homepage+banner.jpg","subTitle":"Novartis in focus: quarterly figures inbound","windowTitle":"Earnings Action","category":"powerplay","title":"Earnings Action","body":"<div>In our Earnings Action section, this time we take a look at the Swiss pharmaceutical giant Novartis, which will publish its latest financial figures on Tuesday. Investors and analysts are eagerly awaiting new insights into the development of key sales drivers such as Entresto, Cosentyx and Pluvicto as well as possible statements on the ongoing share buyback program.<\/div>\n<div>Following the successful spin-off of Sandoz, Novartis is focusing entirely on patent-protected medicines - a strategic move that should further boost growth in the future. Expectations are correspondingly high: it will be particularly interesting to see how much Novartis has benefited from price adjustments in the USA and new product launches.<\/div>\n\n<div>Analysts expect:<\/div>\n<ul>\n<li>Solid revenue growth in the mid-single-digit range<\/li>\n<li>Margin improvements driven by efficiency programs<\/li>\n<li>Clear guidance for full-year 2025<\/li>\n<\/ul>\n<div>Depending on whether Novartis exceeds or disappoints expectations, the price swings could be more pronounced. There are interesting trading opportunities for active investors - especially with Mini-Futures.<\/div>\n<div>Mini futures make it possible to bet on rising (Mini-Future long &#x1F4C8) or falling (Mini-Future short &#x1F4C9) prices with a small capital investment. Especially around the publication of quarterly figures, when fluctuations often increase, these products offer effective leverage to participate in short-term movements.<\/div>\n<h3>Mini-Futures<\/h3>\n<div>  \n        \n                                                                                                                                                                                                                                                                            \n            <leverage-saved-search :columns=\"[ 'engine.isin', 'engine.valor', 'Type', 'Direction', 'engine.underlying', 'engine.currency-abbr', 'Strike', 'Leverage', 'Ratio', 'engine.maturity', 'Bid', 'Ask']\" :filter=\"{&quot;conditions&quot;:{&quot;+calendar.firstTradingDate:[* TO now/d]&quot;:true,&quot;-identification.status:EXPIRED&quot;:true,&quot;+_exists_:price.ask +price.state:(\\&quot;OPEN\\&quot;, \\&quot;CLOSED\\&quot;)&quot;:false},&quot;omni&quot;:&quot;\\&quot;CH1432459548\\&quot; \\&quot;CH0513600293\\&quot; \\&quot;CH1427532580\\&quot; \\&quot;CH1403580132\\&quot;&quot;}\" />\n  <\/div>\n<div><ltq-button color=\"primary\" url=\"https://structuredproducts-ch.leonteq.com/leverage/Wnd?language_id=1\" label=\"Discover more Leverage Products on Novartis\"><\/ltq-button><\/div>\n<div>      <p>We look forward to answering all of your questions about our products and how they are traded. Please don't hesitate to get in touch! Phone: <a href=\"tel:+41588001111\">058 800 11 11<\/a>, email <a href=\"mailto:info@leonteq.com\">info@leonteq.com<\/a> or <a href=\"/contact\" title=\"Contact\">contact us here<\/a>.\n<\/p>\n  <\/div>","url":"leverage-novn-q1-2025","thumbnailUrl":"https://structuredproducts-ch-pub-uat.leonteq.com/product-news/thumbnail/rfb_earnings_action_leonteq_structured_products_thumbnail.jpg"}